Metastatic breast cancer in patients with schizophrenia

By Meyer Aaron A.  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 359-364

Spandidos Publications

Access to resources Recommend Favorite

Number of Treatment Cycles Influences Development of Cytotoxic T Cells in Metastatic Breast Cancer Patients – A Phase I/II Study

By Wright Stephen E.   Rewers-Felkins Kathleen A.   Quinlin Imelda S.   Phillips Catherine A.   Townsend Mary   Philip Ramila   Zorsky Paul   Klug Panpit   Dai Lijun   Hussain Mohammad   Thomas Aabu A.   Sundaramurthy Chithraleka  

Immunological Investigations, Vol. 39, Iss. 6, 2010-01 ,pp. : 570-586

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic Agents in the Treatment of HER2-Negative Metastatic breast Cancer: A Brief Review

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite

Main complications and results of treatment with intraarterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer

By                  

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 745-748

Spandidos Publications

Access to resources Recommend Favorite

Fulminant hepatic failure caused by hepatitis B virus activation after chemotherapy for breast cancer treated with liver transplantation: a case report

By Hung C.-M.   Jeng L.-B.   Lee W.-C.   Yu M.-C.   Kuo L.-M.   Chen M.-F.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 387-388

Elsevier

Access to resources Recommend Favorite